It has been reported that BHLHE40 can promote SNAI1 and SNAI2 expression and inhibit the expression of CLDN1, CLDN4, and CDH2 in breast cancer, promoting the migration and invasion of tumor cells (43). Here, CLDN1 is linked to breast carcinoma.